Loss of imprinting of human insulin-like growth factor II gene, IGF2, in acute myeloid leukemia.

Genomic imprinting is a non-Mendelian form of gene regulation resulting in differential allelic expression of a gene and plays an important role in the development of certain types of cancer and genetic diseases. Imprinting of IGF2 was demonstrated in normal placenta and fetal kidney by showing monoallelic paternal expression. In contrast, several kinds of tumor showed biallelic expression of IGF2, suggesting that relaxation of the normal imprinting of this growth cytokine may be a feature of some tumors. In this study we wished to determine whether relaxation of IGF2 imprinting was also common in human leukemias. An intragenic Apa I polymorphism within the 3' untranslated region of the gene was used to examine allele-specific transcription in leukemic blasts derived from 24 primary patients with acute myeloid leukemia by RT-PCR. Leukemic samples from 12 of the 24 leukemia patients were identified as heterozygous for IGF2 and potentially informative for the RT-PCR assay. RNA-PCR from these informative leukemia samples studied showed biallelic expression of IGF2, indicating loss of normal imprinting of this gene to be very frequent. In conclusion, constitutional loss of monoallelic expression in 50% of the leukemia samples tested suggests that abnormal imprinting of IGF2 could play an important role in either leukemogenesis or cytokine dysregulation for leukemic cells.

[1]  J. Sambrook,et al.  Molecular Cloning: A Laboratory Manual , 2001 .

[2]  F. Kashanchi,et al.  Regulation of insulin-like growth factor II P3 promotor by p53: a potential mechanism for tumorigenesis. , 1996, Cancer research.

[3]  S. Zhan,et al.  Loss of imprinting of IGF2 in Ewing's sarcoma. , 1995, Oncogene.

[4]  G. Ciliberto,et al.  Loss of heterozygosity of imprinted genes in SV40 t/T antigen-induced hepatocellular carcinomas. , 1995, Oncogene.

[5]  A. Reeve,et al.  Altered specificity of IGF2 promoter imprinting during fetal development and onset of Wilms tumour. , 1995, Oncogene.

[6]  H. Heng,et al.  Differential expression of a basic helix-loop-helix phosphoprotein gene, G0S8, in acute leukemia and localization to human chromosome 1q31. , 1995, Leukemia.

[7]  T. Ekström,et al.  Expression, promoter usage and parental imprinting status of insulin-like growth factor II (IGF2) in human hepatoblastoma: uncoupling of IGF2 and H19 imprinting. , 1995, Oncogene.

[8]  M. Koyama,et al.  Loss of imprinting in choriocarcinoma , 1995, Nature Genetics.

[9]  J. Goodman,et al.  Hypomethylation of DNA: An epigenetic mechanism involved in tumor promotion , 1994, Molecular carcinogenesis.

[10]  A. Hoffman,et al.  Promoter-specific imprinting of the human insulin-like growth factor-II gene , 1994, Nature.

[11]  R. Ueda,et al.  Parental origin of 11p15 deletions in human lung cancer. , 1994, Oncogene.

[12]  E. Mariman,et al.  Biallelic expression of the H19 and IGF2 genes in human testicular germ cell tumors. , 1994, Journal of the National Cancer Institute.

[13]  A. Feinberg,et al.  Genomic imprinting, DNA methylation, and cancer. , 1994, Journal of the National Cancer Institute. Monographs.

[14]  A. Feinberg,et al.  Loss of imprinting of IGF2 is linked to reduced expression and abnormal methylation of H19 in Wilms' tumour , 1994, Nature Genetics.

[15]  D. Barlow.  Imprinting: a gamete's point of view. , 1994, Trends in genetics : TIG.

[16]  S. Rastan,et al.  Evidence that random and imprinted Xist expression is controlled by preemptive methylation , 1994, Cell.

[17]  R. Ueda,et al.  Altered imprinting in lung cancer , 1994, Nature Genetics.

[18]  R. Schultz,et al.  Igf2r and Igf2 gene expression in androgenetic, gynogenetic, and parthenogenetic preimplantation mouse embryos: absence of regulation by genomic imprinting. , 1994, Genes & development.

[19]  M. Eccles,et al.  Constitutional relaxation of insulin–like growth factor II gene imprinting associated with Wilms' tumour and gigantism , 1993, Nature Genetics.

[20]  L. Gibson,et al.  Insulin-like growth factor-1 potentiates expansion of interleukin-7-dependent pro-B cells. , 1993, Blood.

[21]  C. Stewart,et al.  Oppositely imprinted genes H19 and insulin-like growth factor 2 are coexpressed in human androgenetic trophoblast. , 1993, American journal of human genetics.

[22]  S. Davies,et al.  Maintenance of genomic imprinting at the IGF2 locus in hepatoblastoma. , 1993, Cancer research.

[23]  R. Weksberg,et al.  Disruption of insulin–like growth factor 2 imprinting in Beckwith–Wiedemann syndrome , 1993, Nature genetics.

[24]  G. Schwartz,et al.  Glycosylated insulin-like growth factor II promoted expansion of granulocyte-macrophage colony-forming cells in serum-deprived liquid cultures of human peripheral blood cells. , 1993, Experimental Hematology.

[25]  D. J. Driscoll,et al.  Modification of 15q11-q13 DNA methylation imprints in unique Angelman and Prader-Willi patients. , 1993, Human molecular genetics.

[26]  A. Feinberg.  Genomic imprinting and gene activation in cancer , 1993, Nature Genetics.

[27]  M. Eccles,et al.  Relaxation of insulin-like growth factor II gene imprinting implicated in Wilms' tumour , 1993, Nature.

[28]  S. Leff,et al.  A candidate mouse model for Prader–Willi syndrome which shows an absence of Snrpn expression , 1992, Nature Genetics.

[29]  Y. Tomino,et al.  Abnormal regulation of insulin-like growth factor gene expression in peripheral blood mononuclear cells from patients with IgA nephropathy. , 1992, American journal of nephrology.

[30]  A. Efstratiadis,et al.  Parental imprinting of the mouse insulin-like growth factor II gene , 1991, Cell.

[31]  D. Barlow,et al.  The mouse insulin-like growth factor type-2 receptor is imprinted and closely linked to the Tme locus , 1991, Nature.

[32]  J. Pintar,et al.  Pattern of the insulin-like growth factor II gene expression during early mouse embryogenesis. , 1990, Development.

[33]  V. Chapman,et al.  Identification of an imprinted U2af binding protein related sequence on mouse chromosome 11 using the RLGS method , 1994, Nature Genetics.

[34]  V. Holan,et al.  A novel cell growth-promoting factor identified in a B cell leukemia cell line, BALL-1. , 1993, Neoplasma (Bratislava).

[35]  N. Dainiak,et al.  Insulin-like growth factors stimulate erythropoiesis in serum-substituted umbilical cord blood cultures. , 1993, Experimental hematology.